Results 31 to 40 of about 168,114 (189)

Coexistence of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the Central Nervous System: A Systematic Review

open access: yesBrain Sciences, 2022
Background: Myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG) has been considered a diagnostic marker for patients with demyelinating disease, termed “MOG-IgG associated disorder” (MOGAD).
Cong Zhao   +6 more
doaj   +1 more source

Clinical Features of Coexisting Anti-NMDAR and MOG Antibody-Associated Encephalitis: A Systematic Review and Meta-Analysis

open access: yesFrontiers in Neurology, 2021
Coexisting anti-NMDAR and MOG antibody (anti-NMDAR-IgG+/MOG-IgG+)-associated encephalitis have garnered great attention. This study aimed to perform a secondary analysis to determine the clinical features of this disease.
Jiayue Ding, Xiangyu Li, Zhiyan Tian
doaj   +1 more source

A multicenter comparison of MOG-IgG cell-based assays [PDF]

open access: yesNeurology, 2019
To compares 3 different myelin oligodendrocyte glycoprotein-immunoglobulin G (IgG) cell-based assays (CBAs) from 3 international centers.Serum samples from 394 patients were as follows: acute disseminated encephalomyelitis (28), seronegative neuromyelitis optica (27), optic neuritis (21 single, 2 relapsing), and longitudinally extensive (10 single, 3 ...
Waters, P   +11 more
openaire   +2 more sources

Clinical and Magnetic Resonance Imaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein

open access: yesFrontiers in Pediatrics, 2022
BackgroundMyelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG)-associated disorders (MOGADs) have been considered as a new inflammatory disease entity of the central nervous system (CNS) and have heterogeneous clinical and imaging presentations.
Meifang Lei   +10 more
doaj   +1 more source

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an Association

open access: yesFrontiers in Immunology, 2021
To determine whether there is a correlation between myelin oligodendrocyte glycoprotein (MOG) antibody-associated diseases and varicella zoster virus (VZV) infection.
Franziska Di Pauli   +12 more
doaj   +1 more source

Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis

open access: yesAnnals of Clinical and Translational Neurology, 2022
Although myelitis is the second most common presentation in adults with myelin oligodendrocyte glycoprotein (MOG) antibody‐associated disease (MOGAD), studies on MOG‐IgG seroprevalence in patients with myelitis episodes are sparse.
Ki Hoon Kim   +5 more
doaj   +1 more source

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders [PDF]

open access: yesJAMA Neurology, 2018
Recent studies have reported a higher relapse rate following an initial inflammatory demyelinating disorder in pediatric patients with persistent seropositivity of antibodies targeting myelin oligodendrocyte glycoprotein (MOG-IgG1). To date, the clinical implications of longitudinal MOG-IgG1 seropositivity using live cell assays with IgG1 secondary ...
A Sebastian, López-Chiriboga   +17 more
openaire   +2 more sources

Intrathecal Production of MOG-IgG

open access: yesNeurology, 2021
Myelin oligodendrocyte glycoprotein (MOG) antibody (Ab)–associated disease (MOGAD) is now a well-recognized demyelinating disease. Despite the phenotypic overlap with both multiple sclerosis and aquaporin-4 (AQP4)-Ab neuromyelitis optica spectrum disorder, cumulative clinical and immunologic evidence clearly discriminates between these conditions.
Yael Hacohen   +2 more
openaire   +3 more sources

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients [PDF]

open access: yes, 2016
Background: Antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) have been reported in patients with aquaporin-4 antibody (AQP4-IgG)-negative neuromyelitis optica spectrum disorders (NMOSD).
Ringelstein, M.   +86 more
core   +2 more sources

Home - About - Disclaimer - Privacy